Akebia Therapeutics, Inc. (AKBA)
1.585
0.00 (0.00%)
USD |
NASDAQ |
Dec 10, 12:39
Akebia Therapeutics Market Cap: 420.61M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 144.81B |
| Plus Therapeutics, Inc. | 92.20M |
| Ironwood Pharmaceuticals, Inc. | 611.67M |
| Pyxis Oncology, Inc. | 262.13M |
| Karyopharm Therapeutics, Inc. | 109.30M |
Market Cap Related Metrics
| PS Ratio | 1.771 |
| Price to Book Value | 10.11 |
| Price to Free Cash Flow | 12.39 |
| Price | 1.585 |
| Earnings Yield | -4.80% |
| Operating PE Ratio | 22.46 |